Last reviewed · How we verify

NCT03677323: VRBLOC

Evaluation of the Efficacy of VR on Pain and Anxiety When Performing an Ultrasound-controlled Ankle Block.

Completed NA Last updated 26 March 2019
What this trial tests

NA trial testing Virtual reality in Hallux Valgus in 60 participants. Completed in 21 February 2019.

Timeline
2 January 2019
Primary endpoint
21 February 2019
21 February 2019

Quick facts

Lead sponsorClinique Saint Jean, France
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date2 January 2019
Primary completion21 February 2019
Estimated completion21 February 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Clinique Saint Jean, France — full company profile →

Who can join

18 and older, any sex, with Hallux Valgus or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to observe or not a reduction on pain and anxiety felt by the patient when performing an ultrasound-controlled ankle block in preparation for forefoot surgery, using a virtual reality device instead of drug sedation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other recruiting trials for Hallux Valgus

Currently open trials in the same condition.

Other Clinique Saint Jean, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03677323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing